Profile
Mr. Benjamin J.
Harshbarger is a Chief Legal Officer at Xilio Therapeutics, Inc. Mr. Harshbarger was previously employed as a Chief Legal Officer by Astria Therapeutics, Inc., a Chief Executive Officer & General Counsel by Novelion Therapeutics, Inc., a General Counsel by Aegerion Pharmaceuticals, Inc., a Senior Director-Corporate Counsel by Cubist Pharmaceuticals, Inc., a Senior Director-Deputy General Counsel by ViaCell, Inc., an Associate General Counsel by Biogen Idec, Inc., and an Associate by Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC.
He received his undergraduate degree from the University of Richmond and a graduate degree from Boston College Law School.
Ben Harshbarger active positions
| Companies | Position | Start |
|---|---|---|
| XILIO THERAPEUTICS, INC. | General Counsel | 28/06/2026 |
Former positions of Ben Harshbarger
| Companies | Position | End |
|---|---|---|
| ASTRIA THERAPEUTICS, INC. | General Counsel | 22/01/2026 |
| NOVELION THERAPEUTICS INC. | Chief Executive Officer | 30/12/2019 |
| AEGERION PHARMACEUTICALS, INC. | General Counsel | 30/06/2016 |
| CUBIST PHARMACEUTICALS INC | General Counsel | 29/02/2012 |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology Provides and develops cellular medicine for the treatment of diseases | Corporate Officer/Principal | 29/02/2008 |
Education of Ben Harshbarger
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Cubist Pharmaceuticals LLC
Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops antibiotics to combat drug-resistant bacterial infections | Health Technology |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology Provides and develops cellular medicine for the treatment of diseases | Health Technology |
Aegerion Pharmaceuticals, Inc.
Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for hyperlipidemia and metabolic diseases | Health Technology |
Astria Therapeutics, Inc.
Astria Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel therapeutics for allergic & immunologic diseases | Health Technology |
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
University of Richmond
University of Richmond Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston College Law School
Boston College Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xilio Therapeutics, Inc.
Xilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies | Health Technology |
Novelion Therapeutics, Inc.
Novelion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets rare disease products, metreleptin and lomitapide | Health Technology |
- Stock Market
- Insiders
- Ben Harshbarger
















